Search results
8 lis 2023 · Alfasigma S.p.A. (“Alfasigma”) announced today that it has, through its wholly owned subsidiary Interstellar Acquisition Inc. (“Interstellar”), successfully completed its tender offer to purchase all outstanding shares of common stock of Intercept Pharmaceuticals, Inc.
- Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
Bologna, Italy & Morristown, N.J., U.S. – November 8, 2023 –...
- Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
8 lis 2023 · Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc. Business Wire. Wed, Nov 8, 2023 5 min read. BOLOGNA, Italy ...
8 lis 2023 · Bologna, Italy & Morristown, N.J., U.S. – November 8, 2023 – Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. ( “Intercept”) announced today the completion of the acquisition of Intercept by Alfasigma through its wholly owned subsidiary Interstellar Acquisition Inc.
26 wrz 2023 · Under the terms of the merger agreement, Alfasigma has agreed to commence a cash tender offer to acquire all issued and outstanding shares of Intercept common stock for US$19.00 per share in cash.
26 wrz 2023 · Intercept Pharmaceuticals (ICPT) to be acquired by Alfasigma in an $800M deal, offering a premium to its IPO price. Read why this deal is good for Alfasigma.
Alfasigma serves clients worldwide. Company profile page for Alfasigma SpA including stock price, company news, executives, board members, and contact information.
11 paź 2023 · BOLOGNA, Italy-- ( BUSINESS WIRE )--Alfasigma S.p.A. (“Alfasigma”) today announced that its wholly-owned subsidiary, Interstellar Acquisition Inc., a Delaware corporation (“Purchaser”), has...
